Skip to main content
Erschienen in: Rheumatology International 12/2007

01.10.2007 | Case Report

Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab

verfasst von: Boris A. Cruz, Dorothy D. Reis, Célia Aparecida A. Araujo, for the Minas Gerais Vasculitis Study Group

Erschienen in: Rheumatology International | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

Sarcoidosis is a chronic disease of unknown etiology characterized by granulomatous infiltration of several organs. Up to two- thirds of patients develop ocular inflammation eventually leading to significant visual loss. Treatment includes corticosteroids and immunosuppressive agents, but refractory cases do occur. In this report, the authors describe two patients with multi-systemic sarcoidosis and refractory retinal vasculitis who experienced an excellent response to infliximab. This report emphasizes the importance of TNF-alpha in the pathophysiology of this disease and warrants further studies with anti-TNF therapy in patients with refractory ocular sarcoidosis.
Literatur
1.
Zurück zum Zitat Jones NP (2002) Sarcoidosis and uveitis. Ophthalmol Clin N Am 15:319– 326CrossRef Jones NP (2002) Sarcoidosis and uveitis. Ophthalmol Clin N Am 15:319– 326CrossRef
2.
Zurück zum Zitat White ES (2006) Infliximab in sarcoidosis: more answers or more questions? Am J Respir Crit Care Med 174:732–3PubMedCrossRef White ES (2006) Infliximab in sarcoidosis: more answers or more questions? Am J Respir Crit Care Med 174:732–3PubMedCrossRef
3.
Zurück zum Zitat Suhler EB, Smith JR, Wertheim MS et al (2005) A prospective trial of infliximab therapy for patients with refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 123:903–912PubMedCrossRef Suhler EB, Smith JR, Wertheim MS et al (2005) A prospective trial of infliximab therapy for patients with refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 123:903–912PubMedCrossRef
4.
Zurück zum Zitat Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127: 1064–71PubMedCrossRef Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127: 1064–71PubMedCrossRef
5.
Zurück zum Zitat Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795–802PubMedCrossRef Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795–802PubMedCrossRef
Metadaten
Titel
Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab
verfasst von
Boris A. Cruz
Dorothy D. Reis
Célia Aparecida A. Araujo
for the Minas Gerais Vasculitis Study Group
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 12/2007
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0359-9

Weitere Artikel der Ausgabe 12/2007

Rheumatology International 12/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.